BioMarin Pharmaceutical | BMRN - أصول متداولة





أصول متداولة تغيير تاريخ
Acadia Pharmaceuticals USD 1.27B 43.88M 2026-09
Agios Pharmaceuticals USD 752.1M 34.43M 2026-09
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Amgen USD 34.36B 598M 2026-09
Bayer EUR 39.6B 5.96B 2026-09
Biogen USD 7.58B 278.7M 2026-09
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
Incyte USD 5.52B 505.2M 2026-09
Insmed USD 1.71B 72.59M 2026-09
Ionis Pharmaceuticals USD 2.36B 129.77M 2026-09
Moderna USD 7.34B 1.53B 2026-09
Neurocrine Biosciences USD 2.01B 370.7M 2026-09
PTC Therapeutics USD 2.54B 79.58M 2026-09
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 31.52B 1.36B 2026-06
Sarepta Therapeutics USD 2.27B 49.06M 2026-09
Ultragenyx Pharmaceutical USD 544M 62M 2026-09
United Therapeutics USD 2.88B 603.5M 2026-09
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09